Paul A. Johnston

Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.

D. L. Taylor, K. Giuliano, C. Strock, 2010, Assay and drug development technologies.

Implementation of a 220,000-Compound HCS Campaign to Identify Disruptors of the Interaction between p53 and hDM2 and Characterization of the Confirmed Hits

D. L. Taylor, K. Giuliano, C. Strock, 2010, Journal of biomolecular screening.

High-throughput automated confocal microscopy imaging screen of a kinase-focused library to identify p38 mitogen-activated protein kinase inhibitors using the GE InCell 3000 analyzer.

Paul A Johnston, O Joseph Trask, O. J. Trask, 2009, Methods in molecular biology.

Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.

Paul A Johnston, Oscar J Trask, O. J. Trask, 2006, Methods in enzymology.

Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.

O. J. Trask, P. Johnston, P. Johnston, 2006, Methods in enzymology.

Synthesis and Biological Activity of a Focused Library of Mitogen‐activated Protein Kinase Phosphatase Inhibitors

Peter Wipf, Paul A Johnston, Donna M Huryn, 2007, Chemical biology & drug design.

Characterization of Allosteric Modulators that Disrupt Androgen Receptor Co-activator Protein-Protein Interactions to Alter Transactivation - Drug Leads for Metastatic Castration Resistant Prostate Cancer.

C. Camacho, C. Strock, Wei Xu, 2023, SLAS discovery : advancing life sciences R & D.